
Shanghai Shen Lian Biomedical Corporation
SSE:688098.SS
5.99 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| -48.749 | 29.85 | 60.971 | 104.459 | 129.367 | 77.957 | 87.58 | 98.678 | 73.472 | 75.844 | 61.14 | 41.823 |
Depreciation & Amortization
| 68.637 | 63.451 | 57.069 | 43.742 | 20.792 | 14.98 | 11.894 | 8.67 | 9.781 | 8.917 | 8.325 | 8.456 |
Deferred Income Tax
| 0 | 0 | 0.631 | 1.459 | -4.315 | -0.123 | -0.112 | 0.632 | 4.912 | 0 | -4.322 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 18.379 | 0 | 0 | 0 | 0 | 0 | 2.842 | 0 |
Change In Working Capital
| 35.193 | -81.756 | -108.11 | -53.24 | -41.034 | -35.357 | 23.778 | -32.886 | -35.515 | -53.914 | 40.608 | 3.97 |
Accounts Receivables
| 5.026 | -52.184 | -78.961 | -27.684 | -29.755 | -47.926 | 26.897 | -34.335 | -46.325 | 6.888 | 42.093 | -25.148 |
Inventory
| 16.682 | 3.58 | -11.897 | -32.27 | -15.521 | 11.626 | -1.235 | -4.169 | -2.253 | 3.411 | -2.1 | -2.872 |
Accounts Payables
| 0 | -33.152 | -17.884 | 5.255 | 8.558 | 1.066 | -1.772 | 4.985 | 8.15 | 0 | 0 | 0 |
Other Working Capital
| 13.485 | 0 | 0.631 | 1.459 | -4.315 | -0.123 | 25.013 | -28.717 | -33.263 | -57.325 | 42.708 | 6.841 |
Other Non Cash Items
| 34.28 | -8.02 | 4.671 | -4.84 | -11.459 | -3.767 | -2.122 | 0.143 | 0.258 | 0.016 | -2.615 | -2.461 |
Operating Cash Flow
| 89.362 | 3.526 | 9.088 | 90.12 | 111.73 | 53.813 | 121.13 | 74.605 | 47.995 | 30.863 | 105.978 | 51.788 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -84.91 | -129.632 | -93.124 | -188.164 | -163.563 | -104.089 | -78.803 | -103.442 | -115.704 | -41.932 | -31.571 | -35.234 |
Acquisitions Net
| 0 | 0 | 0.855 | 0.496 | 0.002 | 104.16 | -0 | 0.445 | -0 | 0.071 | 0 | 0.444 |
Purchases Of Investments
| -946.28 | -1,303.65 | -1,691.1 | -3,190.2 | -3,617.5 | -1,520.54 | -533 | -90 | -100 | -458 | -820 | -230 |
Sales Maturities Of Investments
| 1,027.513 | 1,445.1 | 1,819.377 | 3,250.658 | 3,690.972 | 993.607 | 535.085 | 90.611 | 140.772 | 541.949 | 706.411 | 295.337 |
Other Investing Activites
| 0 | 10.046 | 0 | 0 | -0.01 | -104.089 | -0.73 | -0.151 | -1.586 | 14.442 | 5.31 | -5.273 |
Investing Cash Flow
| -3.678 | 21.864 | 36.009 | -127.211 | -90.099 | -630.951 | -77.449 | -102.537 | -76.519 | 56.53 | -139.85 | 25.274 |
Financing Activities: | ||||||||||||
Debt Repayment
| 14 | 0 | 0 | 0 | -30 | 0 | 2.252 | 27.748 | -45 | 0 | 0 | -3.495 |
Common Stock Issued
| 0 | 0 | 0 | 0 | -0.878 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -14.347 | -32.774 | -36.958 | -40.97 | -32.776 | -28.776 | -10.48 | -15.844 | -10.093 | -113.502 | -70.446 | -13.833 |
Other Financing Activities
| -19.009 | -0.368 | 0.115 | 8.503 | -1.084 | 401.932 | 204.5 | 0 | 83.85 | 45 | 0 | 7.377 |
Financing Cash Flow
| -19.356 | -33.142 | -36.696 | -32.304 | -63.86 | 371.589 | 196.272 | 11.904 | 28.757 | -68.502 | -70.446 | -9.951 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0.638 | -0 | 0 | 0 |
Net Change In Cash
| 66.328 | -7.705 | 8.401 | -69.395 | -42.229 | -205.549 | 239.953 | -16.028 | 0.871 | 18.891 | -104.318 | 67.112 |
Cash At End Of Period
| 111.169 | 44.841 | 52.546 | 44.145 | 113.539 | 155.768 | 361.317 | 121.365 | 137.392 | 136.521 | 117.63 | 221.947 |